Island Pharmaceuticals
Island Pharmaceuticals is a startup headquartered in Camberwell, Australia, founded in 2020. It has raised at least $1.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Island Pharmaceuticals has raised at least $1.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Island Pharmaceuticals sits inside the Melbourne R&D ecosystem in the Global R&D Labs Directory.
Related
Questions and answers
What does Island Pharmaceuticals do?
Island Pharmaceuticals is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Island Pharmaceuticals raised?
At least $1.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Island Pharmaceuticals based?
Island Pharmaceuticals is headquartered in Camberwell, Australia.
When was Island Pharmaceuticals founded?
Island Pharmaceuticals was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.